| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Biotechnology
| Gilead Sciences is strategically enhancing its product and service development through a significant focus on autoimmune treatments, emphasizing innovation with novel therapies. Key efforts include the expansion of its inflammation portfolio and the development of targeted therapies like T cell engagers. The company is making strides in advancing drug candidates such as gamgertamig, which showcases its commitment to addressing unmet medical needs. This robust approach positions Gilead as a leader in the competitive landscape of autoimmune disease treatments. |
| The price action of Gilead Sciences (GILD) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at -1.9 is very bearish. The market sentiment at 0.9 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. There is no clear direction for GILD since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 1.4, and the negative at -0.5 on 2026-03-24. The forces of Stock Price Trend (-1.9), and Sector Price Trend (-1.9) will drive down the price. The forces of Market Risk Appetite (0), Price Level Sentiment (0.5), Option Sentiment (1.5), Valuation Sentiment (2.7), and Sentiment towards Fundamentals (3.9) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| GILD | ||||||||||||||
| Date | Attention | Price | StdDev | Price Level | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-24 | 0%(0%) | 138.11 | 2.69% | 6 | 0.56% | -0.7% | -1.9 | 0.1 | 0.3% | 1 | Wait | 50% | 3.9 | 6 |
| 2026-03-23 | 0%(0%) | 137.34 | 2.51% | -6 | 0.09% | -0.69% | -2.3 | -0.2 | 1.1% | 1.1 | Short | 70% | 2.7 | 6 |
| 2026-03-22 | 0%(0%) | -2 | -0.2 | 0.1 | 0.7 | -1 | ||||||||
| 2026-03-21 | 0%(0%) | -2 | -0.2 | 0.3 | 1.1 | -1 | ||||||||
| 2026-03-20 | 0%(0%) | 137.21 | 2.27% | -18 | -2.76% | -0.41% | -2 | -0.6 | 1.1% | 0.7 | Short | 70% | 1.1 | -1 |
| 2026-03-19 | 0%(0%) | 141.11 | 1.91% | 1 | -0.13% | -0.28% | -1.2 | -0.2 | 1.2% | 1 | Wait | 50% | 1.6 | -1 |
| 2026-03-18 | 0%(0%) | 141.29 | 1.85% | -4 | -2.15% | -0.48% | -1.5 | -0.5 | 1.2% | 0.9 | Short | 70% | 0.9 | -1 |
| 2026-03-17 | 0%(0%) | 144.4 | 1.79% | 21 | -0.56% | -0.27% | -1.3 | -0.1 | 0.3% | 0.8 | Short | 55% | 0.8 | -1 |
| 2026-03-16 | 0%(0%) | 145.21 | 2.06% | 27 | 0.15% | -0.34% | -0.8 | -0.1 | 0.5% | 0.4 | Short | 55% | 1 | -1 |
| 2026-03-15 | 0%(0%) | -0.4 | -0.1 | 0.7 | 1.5 | -1 | ||||||||
| Wait is the preferred trading strategy with 50% chance of being right. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||
| Analysis | ||
| ● Gilead Sciences (GILD) Equity Research Report Mon. Mar 2, 2026 | ||
| 2026-03-24 17:09:06 The acquisition is likely to positively influence Gilead's stock performance by showcasing growth potential in the autoimmune treatment market. |
| 2026-03-24 17:09:06 Gilead's plans to collaborate with a Belgian pharmaceutical company for the development of gamgertamig indicate a strategic partnership to enhance therapeutic pipeline. |
| 2026-03-24 17:09:06 Ouro Medicines' lead drug candidate, gamgertamig, represents a forward-looking approach to innovate in T cell engager therapies. |
| 2026-03-24 17:09:06 The acquisition strengthens Gilead's inflammation portfolio, showcasing its commitment to enhance treatment options for autoimmune diseases. |
| 2026-03-24 17:09:06 Gilead Sciences' acquisition of Ouro Medicines is a significant investment aimed at expanding its portfolio in the autoimmune therapy sector. |
| 2026-03-24 09:35:16 Gilead's collaboration with a Belgian pharma company indicates a trend towards partnerships that enhance R&D capabilities. |
| 2026-03-24 09:35:16 The emphasis on developing gamgertamig reflects Gilead's commitment to innovation in drug development, especially in the area of immune resetting treatments. |
| 2026-03-24 09:35:16 Gilead's acquisition of Ouro Medicines signals a strategic move towards expanding its drug portfolio and enhancing future growth prospects. |